Stock APLLTD ALEMBIC PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Alembic Pharmaceuticals Limited

Equities

APLLTD

INE901L01018

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 06:49:37 2025-02-14 EST 		5-day change 1st Jan Change
818.15 INR -0.92% Intraday chart for Alembic Pharmaceuticals Limited -7.73% -23.27%
02-11 Alembic Pharmaceuticals Limited Announces Cessation of Dhananjay Wyawahare as Head-Site Operations CI
02-04 Alembic Pharmaceuticals' Consolidated Profit Declines in Fiscal Q3 MT

Search
See the results
Alembic Pharmaceuticals Limited Announces Cessation of Dhananjay Wyawahare as Head-Site Operations
02-11
 CI
Alembic Pharmaceuticals' Consolidated Profit Declines in Fiscal Q3
02-04
 MT
Alembic Pharmaceuticals Limited Announces Completion of Tenure of Archana Hingorani as Independent Director
02-03
 CI
India's Alembic Pharma posts lower Q3 profit on weak domestic demand
02-03
 RE
Alembic Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024
02-03
 CI
Alembic Pharma Q3 Consol Profit 1.38 Billion Rupees
02-03
 RE
Indian Equities Close Higher on Wednesday, Led by IT, Energy Stocks
01-15
 MT
Alembic Pharmaceuticals Gets US FDA Nod for Brexpiprazole Tablets
01-15
 MT
Alembic Pharmaceuticals Limited Announces USFDA Final Approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg
01-15
 CI
Indian Equities Tumble as US Fed's 2025 Rate Outlook Spooks Investors
12-20
 MT
Alembic Pharmaceuticals Gets US FDA Final Nod for Anti-Epileptic Drug
12-20
 MT
Alembic Pharmaceuticals Limited Announces USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg
12-20
 CI
Indian Equities Close with Modest Gains as Select Heavyweights Offset Gains in Banking, IT
12-04
 MT
Alembic Pharma Gets Tentative US FDA Nod for Olopatadine Hydrochloride Ophthalmic Solution
12-04
 MT
Alembic Pharmaceuticals Limited Announces USFDA Tentative Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7%
12-04
 CI
Alembic Pharma Gets Five Observations from US FDA after Jarod, India Unit Inspection; Shares Up 5%
11-24
 MT
Indian Equities Tank on Tuesday as Investors Keep 'Sell on Rise' Strategy
11-12
 MT
Alembic Pharmaceuticals Gets US FDA Final Nod for Ivabradine Tablets
11-12
 MT
Alembic Pharmaceuticals Limited Receives USFDA Final Approval for Ivabradine Tablets, 5 Mg and 7.5 Mg
11-12
 CI
Indian Equities Close Flat on Monday on Profit Taking
11-11
 MT
Alembic Pharmaceuticals Gets Final US FDA Nod for Diltiazem Hydrochloride Capsules
11-11
 MT
Alembic Pharmaceuticals Limited, Q2 2025 Earnings Call, Nov 07, 2024
11-07
Indian drugmaker Alembic Pharma misses Q2 profit view as US sales growth slows
11-07
 RE
Alembic Pharmaceuticals Limited Announces Superannuation of Vipul Gandhi, Head - Business Development - Formulations
11-07
 CI
Alembic Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
11-07
 CI
Become a member to access more news.
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. APLLTD Stock
  4. News Alembic Pharmaceuticals Limited
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition